Close

Radius Health (RDUS) Says Positive Abaloparatide Phase 3 Data Published in JBMR

Go back to Radius Health (RDUS) Says Positive Abaloparatide Phase 3 Data Published in JBMR
(NASDAQ: RDUS) Delayed: 17.91 +0.27 (1.53%)
Previous Close $17.64    52 Week High $75.47 
Open $17.54    52 Week Low $24.75 
Day High $17.94    P/E N/A 
Day Low $17.38    EPS $0.00 
Volume 324,168